BTIG Reiterates Buy on Perspective Therapeutics, Maintains $14 Price Target

Benzinga · 3d ago
BTIG analyst Jeet Mukherjee reiterates Perspective Therapeutics (AMEX:CATX) with a Buy and maintains $14 price target.